Utah Medical Products (UTMD) Shares Outstanding (2010 - 2026)

Utah Medical Products has reported Shares Outstanding for 17 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 2.96% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 2.96% YoY), and the FY2025 full-year result was $3.2 million, down 4.47% from the prior year.
• Shares Outstanding for Q1 2026 stood at $3.2 million, roughly flat from $3.2 million in the prior quarter.
• The five-year high for Shares Outstanding was $3.7 million in Q1 2022, with the low at $3.2 million in Q1 2026.
• Average Shares Outstanding over 5 years is $3.5 million, with a median of $3.6 million recorded in 2024.
• Year-over-year, Shares Outstanding grew 0.25% in 2022 and slipped 8.56% in 2025.
• Tracing UTMD's Shares Outstanding over 5 years: stood at $3.6 million in 2022, then advanced by 0.06% to $3.6 million in 2023, then declined by 8.13% to $3.3 million in 2024, then declined by 4.47% to $3.2 million in 2025, then dropped by 0.06% to $3.2 million in 2026.
• The last three Shares Outstanding figures came in at $3.2 million (Q1 2026), $3.2 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison